The FDA is apparently not charmed by the mischievous “Lipid Lurkers” in an Esperion Therapeutics commercial for ...
Company Transitions from Infrastructure Buildout to Active Market Execution as Expanded 510(k) Review Enters Final ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved Xolair for the reduction of allergic reactions in children and adults with immunoglobulin E ...
FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject clinical ...
Several years ago, a casting director working on a commercial for the NovoLog FlexPen, a dial-a-dose insulin injector from Novo Nordisk, called a friend and urged her to try out. The friend, Vivicca ...
Hosted on MSN
Hims & Hers responds to controversy over Super Bowl weight loss drug commercial: 'We're calling for change'
On Sunday, Hims & Hers Health will have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to bar the game’s host, Fox, from broadcasting it. Why? Experts and ...
The FDA issued a third complete response letter for ONS-5010/Lytenava, requesting confirmatory efficacy evidence for wet AMD treatment. Lytenava is an ophthalmic bevacizumab formulation, potentially ...
The U.S. Food and Drug Administration (FDA), together with the U.S. Department of Agriculture (USDA), recently announced that the FDA-approved commercial milk pasteurization process effectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback